Newsletters

  • All
  • Incentives
  • Jobs
  • Media & Graphics
  • PK & PK-PD
  • R&D Insight
  • Wonkish
  • Y2017
  • Y2018
  • Y2019
  • Y2020
  • Y2021
All
  • All
  • Incentives
  • Jobs
  • Media & Graphics
  • PK & PK-PD
  • R&D Insight
  • Wonkish
  • Y2017
  • Y2018
  • Y2019
  • Y2020
  • Y2021
Media & GraphicsY2017

Superb PBS Newshour segment on agricultural use of antibiotics + McKeena’s Big Chicken book

Dear All:  I wrote a few weeks ago about the Stopping Superbugs series from PBS Newshour. PBS has since then added some superb new …

Read More >
R&D InsightWonkish

Lessons in Discovery from Lynn Silver + Pro-con on alternatives to antibiotics

Dear All: “Good decisions come from experience, and experience comes from bad decisions … and paying attention.” You’ve probably heard …

Read More >
PK & PK-PDY2017

High-resolution (effectively 3-D) drug concentration measurements in tissues

Dear All:  I’m really not trying to flood your inbox with email, but when ideas surface I do like to …

Read More >
PK & PK-PDY2017

Real-time continuous in vivo drug monitoring

Dear All:  I recently became aware of a technology for real-time continuous in vivo monitoring of drug levels that I …

Read More >
R&D InsightY2017

FDA Grand Rounds: The comprehensive in vitro proarrhythmia assay (CiPA) initiative

Dear All:  Per an email received today, there will be an FDA Grand Rounds webcast on 14 Sep 2017 (noon-1p …

Read More >
IncentivesY2017

UK-China AMR Collaboration Competition

Dear All:  It is great to see that the UK Department of Health (DH) and the Chinese Ministry of Science and …

Read More >
IncentivesMedia & Graphics

Pull incentives for antibiotics: Duke-Margolis PAVE policy paper and PBS Newshour segments

Dear All:  We can’t say it too often … our current approach to buying antibiotics is broken in that it …

Read More >
R&D InsightY2017

Final FDA Unmet Need Guidance!

Dear All:  Just out in the last 24h is the announcement that FDA’s 2013 Unmet Need Guidance has now been released …

Read More >
R&D InsightY2017

Using Real-World Evidence: FDA Workshop on 13 Sep 2017

Dear All:  There is a newly announced FDA workshop on 13 Sep on using real-world evidence. Here is the link and I’ve …

Read More >
Media & GraphicsY2017

PBS FRONTLINE: Hunting the Nightmare Bacteria

Dear All:  Frontline will today broadcast an updated version of the excellent Hunting the Nightmare Bacteria show that first broadcast in 2013. Here’s …

Read More >
IncentivesY2017

Powered by CARB-X: Portfolio expansion announced today!

​Dear All: CARB-X has today announced funding of 7 more companies, bringing the total funded portfolio to 17 potential new therapies (or preventatives) and …

Read More >
R&D InsightY2017

Workshop on TB drugs: Lessons for the antibacterial community

Dear All: ​I listened with interest to the 19 July 2017 FDA Workshop entitled “Development of New Tuberculosis Treatment Regimens– …

Read More >
IncentivesY2017

G20 declaration – Statements about action on AMR

Dear All: ​The G20 have released a declaration in which they specifically discuss their intent around AMR. See below a …

Read More >
IncentivesY2017

Lancet ID Commentary to the G20 on behalf of the DRIVE-AB Steering Committee

I am pleased to say that a commentary to the G20 on behalf of the DRIVE-AB Steering Committee has now …

Read More >
R&D InsightWonkish

Developing systemic & inhaled antibiotics for lung infections

Dear All: I missed it personally, but by all reports the session on 3 June 2017 at ASM Microbe entitled …

Read More >
IncentivesY2017

New European Action Plan on AMR

Dear All: ​An updated European One Health Action Plan on AMR was released today. See links and text excerpts below …

Read More >
R&D InsightY2017

Delafloxacin approval / Good example of a modern label

Dear All: FDA’s approval of delafloxacin (BAXDELA) was announced on 20 June 2017 and the label can be found here. In …

Read More >
R&D InsightY2017

FNIH’s submission to the HABP/VABP docket

Dear All: After a multi-year gestation period (my notes on this project go back to 2012!!), a comment on the …

Read More >
PK & PK-PDWonkish

NIAID workshop: What is a robust PK-PD package?

Dear All: The ~150 of us who gathered in Washington yesterday and today for the NIAID’s PK-PD workshop enjoyed a …

Read More >
IncentivesY2017

Assessing antibiotic value: Two papers on antibiotic-specific gaps in traditional Health Technology Assessments

Dear All: Among various paradoxes that surround antibiotic development, the challenge for health technology assessment (HTA) is often implied but …

Read More >
Scroll to Top